Subscribe to our newsletter
Get the latest updates delivered to your inbox every day, and stay up-to-date for free 🧠📈
Share
Linkedin
Twitter
Facebook
Whatsapp
Copy Link
Researchers have achieved the first complete reading of a sealed Herculaneum scroll carbonised by Mount Vesuvius in 79 AD. Using AI-powered 3D scanning and advanced X-ray imaging, the Vesuvius Challenge team digitally unrolled the charred papyrus without physically opening it, uncovering 1.5 meters of text on Stoic philosophy dating back over 2,000 years.
NVIDIA unveiled the BioNeMo Agent Toolkit, providing domain-specific tools for AI agents in life sciences research. The toolkit combines over a decade of NVIDIA's life sciences libraries with technologies like Nemotron and NIM microservices, enabling agents to execute complex scientific workflows. Over 50 companies, including Lilly, OpenAI, Anthropic, and Schrödinger, are already adopting the platform to accelerate drug discovery and biological research.
Natasha Martin from UC San Diego has secured a prestigious $5.6 million NIH Avant-Garde Award to develop AI tools that prevent HIV, hepatitis C, and overdose. The AMPLIFY project will create digital twins—AI-powered simulations trained on community data—to help public health departments allocate resources and design interventions tailored to people who use drugs across the United States.
Researchers at UCLA Health Jonsson Comprehensive Cancer Center developed an AI platform that combines 3D bioprinting, advanced imaging, and artificial intelligence to monitor how cancer responds to treatment. The technology analyzes thousands of patient-derived tumor organoids simultaneously, detecting rare resistant tumor populations and helping identify promising therapies for rare and hard-to-treat cancers.
Insilico Medicine has partnered with South Korea's SK Biopharmaceuticals in a deal worth over $2.5 billion to develop AI-driven neuroimmune therapies. The collaboration combines Insilico's Pharma.AI platform with SK's clinical expertise to accelerate treatments for central nervous system disorders, marking Insilico's largest Asia-Pacific partnership to date.
Bayer AG has announced a collaboration with Iambic Therapeutics to develop small molecule medicines using AI-driven platforms including Enchant and NeuralPLexer technologies. The partnership aims to tackle difficult-to-drug targets and reduce the traditional 10-15 year drug discovery timeline that costs approximately $2.6 billion with over 90% clinical trial failure rates.
A Microsoft AI researcher constructed a functioning neural network inside Age of Empires II using goats, grass, and bridges to illustrate the absurdity of assuming LLMs possess human-like consciousness. Adrian de Wynter's experiment demonstrates that over 57% of recent computer science papers incorrectly assume chatbots have anthropomorphic traits without proper experimental protocols.
Users across social media report ChatGPT suddenly got smarter this week, sparking speculation that OpenAI is quietly testing GPT-5.6 inside its platform. The suspected new AI model shows stronger reasoning capabilities and advanced 3D generation, but takes significantly longer to process complex tasks—up to 87 minutes compared to GPT-5.5's 34 minutes in some tests.
Researchers at the University of Pennsylvania used AI to uncover a surprising source of antibiotics: prion proteins known for causing fatal brain diseases. The deep-learning platform identified over 1,000 antimicrobial peptides called prionins, with dozens showing strong activity against drug-resistant bacteria in lab and mouse tests.
NASA tested ERNEST, a compact four-wheeled prototype rover, across 16 miles of California desert terrain with minimal human intervention. The next-generation rover prototype achieved speeds up to 0.6 mph—ten times faster than current Mars rovers—while demonstrating advanced robotic autonomy and the ability to lift its wheels over obstacles that would stop Curiosity and Perseverance.
Hexaware Technologies is investing £25 million to expand its UK operations, creating around 1,200 jobs in AI, digital services, and quantum computing. The Carlyle-backed firm will establish new R&D centers in Manchester and Leeds while expanding its Birmingham delivery center over the next three to five years. The investment was recognized at the G7 Summit as part of the UK government's AI and clean energy agenda.
Researchers at Harvard's Wyss Institute used deep learning to screen 6 million compounds and identified two promising candidates against multi-drug resistant Neisseria gonorrhoeae. The lead compound, called A1, targets alanine racemase, an enzyme critical for bacterial cell wall formation. The study marks the first use of Organ Chip technology for antibiotic preclinical testing, offering a faster validation pipeline.
XDOF emerged from stealth with $70 million to tackle what may be AI robotics' biggest obstacle: the lack of quality training data. Unlike language models trained on internet text, robots need data capturing physical interactions—and that barely exists. The startup is building data pipelines and teleoperation systems that frontier labs are already using, while releasing the largest open-source robot manipulation dataset to date.
Nvidia's GEAR lab has developed ENPIRE, an agent harness framework that enables AI coding agents to autonomously direct robot training without human supervision. The system achieved 99% success rates on tasks like GPU installation and pin insertion, with eight-robot teams completing training in just two hours.
University of Florida researchers trained machine learning models on retinal photographs from over 40,000 patients to identify early Alzheimer's disease risk factors. The AI-powered analysis detected biological and lifestyle indicators like blood pressure, smoking, and insomnia by examining the retina's arteries and optic nerve, offering a low-cost alternative to expensive brain scans.
Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Follow topics that matter to you and stay ahead.